We’re pleased to announce that Arrotek will be attending the upcoming TCT 2025 (Transcatheter Cardiovascular Therapeutics) conference, taking place October 27–30 in San Francisco, California.
TCT is one of the leading events in the field of interventional cardiovascular medicine, bringing together innovators, clinicians, and industry leaders from around the world. We’re excited to be part of the conversation around the future of cardiovascular technologies and to connect with those driving the next generation of life-saving devices.
At Arrotek, we specialize in taking medical devices from early concept through to full-scale production. With particular expertise in cardiovascular applications, our team has supported development programs across multiple cardiovascular areas.
Whether you’re a start-up looking to accelerate development or an established company preparing for scale-up, our integrated design, development, and manufacturing services can help bring your device to market faster and with confidence.
If you’re attending TCT and would like to learn more about how we can support your project, we’d love to meet you there.
Contact us to schedule a meeting at TCT San Francisco, or email [email protected]
